Riskpilot← Back to searchSign inGet full accessCarmel Pharma Aktiebolag
ABActiveOrg 5565337648Marieviksgatan 25Activities of holding companies · NACE 6421Est. 19960 employees
Revenue 2025
SEK 717K
-99% vs 2024
EBITDA margin
99.8%
-99% vs 2024
Equity ratio
95.6%
Financial strength
Net profit 2025
SEK 73K
+1565% vs 2024
| Revenue | SEK 717K | -99% |
| EBITDA | SEK 715K | -99% |
| Net profit | SEK 73K | +1565% |
| Total assets | SEK 462K | -100% |
| Equity | SEK 441K | -100% |
| Employees | 0 | — |
Legal name
Carmel Pharma Aktiebolag
Org number
5565337648
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
23 augusti 1996
Share capital
SEK 8 866
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas var för sig av Braunstein, Hans Fredrik Lukasavage, Jeanne Patricia
Company purpose
Bolaget skall bedriva forskning, utveckling och kommersialisering av medicintekniska produkter samt äga och förvalta fast och lös egendom samt bedriva därmed förenlig verksamhet.
Address
Marieviksgatan 25
Phone
+4687755150
Email
nordicfinance@bd.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 56 467 | 68 085 | 71 574 | 78 405 | 717 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | 55 084 | 66 944 | 70 079 | 76 953 | 715 |
| Depreciation & amort. | — | — | — | — | −0 |
| EBIT | 55 084 | 66 944 | 70 079 | 76 953 | 715 |
| Net financials | 3 128 | 1 184 | 12 458 | 21 103 | 0 |
| Profit before tax | 3 104 | −34 | 3 | −5 | 92 |
| Tax | −197 | −51 | 47 | −0 | −19 |
| Net profit | 2 907 | −85 | 50 | −5 | 73 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 424 922 | 492 580 | 452 169 | 467 781 | 462 |
| Equity | 368 241 | 368 156 | 368 206 | 368 200 | 441 |
| Long-term debt | 56 287 | 0 | 0 | 0 | 0 |
| Short-term debt | 394 | 124 424 | 83 963 | 99 581 | 20 |
| Total debt | 56 681 | 124 424 | 83 963 | 99 581 | 20 |
EBITDA margin
99.8%
This company
15.8%
Market median
+532% vs market
20212025
Equity ratio
95.6%
This company
38.2%
Market median
+150% vs market
20212025
Return on equity
16.6%
This company
18.4%
Market median
+10% vs market
20212025
Net profit margin
10.2%
This company
8.1%
Market median
+26% vs market
20212025
Asset turnover
1.55×
This company
1.12×
Market median
+38% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JP External Signatory | External Signatory | 2025 |
BH | Audit | 2022 |
| Former (1) | ||
SJ External Signatory | External Signatory | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2026 | |
| Former (4) | ||
| Chairman | 2022 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2024 – 2026 | |
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BECTON DICKINSON LUXEMBOURG HOLDINGS II S.?.R.L.Becton Dickinson Sweden Holdings AB
Carmel Pharma Aktiebolag (this company)Board members of Carmel Pharma Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jeanne Patricia Lukasavage | External Signatory | 0 companies |
| Björn Håkan Aspenblad | Audit | 0 companies |
| Scott Jeffrey Rittman | External Signatory | 0 companies |
| Helena Elisabeth Gomér Bragd | Chairman | 0 companies |
| Hans Fredrik Braunstein | Chairman | 0 companies |
| Karl-Arne Olsson | Board of Directors | 0 companies |
| Stefaan De Boeck | Board of Directors | 0 companies |
| Claudia Maria Anna Ciambriello | Board of Directors | 0 companies |
| Roderick Emery Parent | Board of Directors | 0 companies |
| Lars Erik Pettersson Linander | Board of Directors | 0 companies |
| Ralf Björkavåg | Board of Directors | 0 companies |